These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 17305478)

  • 1. T cell costimulatory and inhibitory receptors as therapeutic targets for inducing anti-tumor immunity.
    Foell J; Hewes B; Mittler RS
    Curr Cancer Drug Targets; 2007 Feb; 7(1):55-70. PubMed ID: 17305478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative co-receptors on lymphocytes.
    Greenwald RJ; Latchman YE; Sharpe AH
    Curr Opin Immunol; 2002 Jun; 14(3):391-6. PubMed ID: 11973140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CD28-B7 costimulatory pathway and its role in autoimmune disease.
    Daikh D; Wofsy D; Imboden JB
    J Leukoc Biol; 1997 Aug; 62(2):156-62. PubMed ID: 9261329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
    Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
    J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting T cell costimulation in autoimmune disease.
    Stuart RW; Racke MK
    Expert Opin Ther Targets; 2002 Jun; 6(3):275-89. PubMed ID: 12223069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28 function: a balance of costimulatory and regulatory signals.
    Bour-Jordan H; Blueston JA
    J Clin Immunol; 2002 Jan; 22(1):1-7. PubMed ID: 11958588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costimulatory molecules and autoimmune thyroid diseases.
    Salmaso C; Olive D; Pesce G; Bagnasco M
    Autoimmunity; 2002 May; 35(3):159-67. PubMed ID: 12389640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients.
    García-Cózar FJ; Molina IJ; Cuadrado MJ; Marubayashi M; Peña J; Santamaría M
    Clin Exp Immunol; 1996 Apr; 104(1):72-9. PubMed ID: 8603537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells.
    Behar SM; Porcelli SA; Beckman EM; Brenner MB
    J Exp Med; 1995 Dec; 182(6):2007-18. PubMed ID: 7500046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting edge: the relative distribution of T cells responding to chemically dominant or minor epitopes of lysozyme is not affected by CD40-CD40 ligand and B7-CD28-CTLA-4 costimulatory pathways.
    DiPaolo RJ; Unanue ER
    J Immunol; 2002 Sep; 169(6):2832-6. PubMed ID: 12218093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costimulation: critical pathways in the immunologic regulation of asthma.
    Bellou A; Finn PW
    Curr Allergy Asthma Rep; 2005 Mar; 5(2):149-54. PubMed ID: 15683616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
    Krummel MF; Allison JP
    J Exp Med; 1995 Aug; 182(2):459-65. PubMed ID: 7543139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation.
    Murphy EE; Terres G; Macatonia SE; Hsieh CS; Mattson J; Lanier L; Wysocka M; Trinchieri G; Murphy K; O'Garra A
    J Exp Med; 1994 Jul; 180(1):223-31. PubMed ID: 7516409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A T cell lymphoma can provide potent co-stimulatory effects to T cells that are not mediated by B7-1, B7-2, CD40, HSA or CD70.
    Nieland JD; Kruisbeek AM
    Int Immunol; 1995 Nov; 7(11):1827-38. PubMed ID: 8580081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of CD4+ T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (trans-costimulation).
    Ding L; Shevach EM
    Eur J Immunol; 1994 Apr; 24(4):859-66. PubMed ID: 7512033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell costimulatory blockade in organ transplantation.
    Maltzman JS; Turka LA
    Cold Spring Harb Perspect Med; 2013 Dec; 3(12):a015537. PubMed ID: 24296352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.
    Carreno BM; Collins M
    Annu Rev Immunol; 2002; 20():29-53. PubMed ID: 11861596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune response induced in vivo by dendritic cells is dependent on B7-1 or B7-2, but the inhibition of both signals does not lead to tolerance.
    Lespagnard L; Mettens P; De Smedt T; Bazin H; Urbain J; Leo O; Moser M
    Int Immunol; 1998 Mar; 10(3):295-304. PubMed ID: 9576617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction by CD28 costimulatory receptor on T cells. B7-1 and B7-2 regulation of tyrosine kinase adaptor molecules.
    Nunès JA; Truneh A; Olive D; Cantrell DA
    J Biol Chem; 1996 Jan; 271(3):1591-8. PubMed ID: 8576157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.